Position in SVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,225,732
-$779,150 QoQ
Shares Held
1,140,244
-1.8% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 184 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. SVRA ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in SVRA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,225,732 | 1,140,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,004,882 | 1,161,672 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,440,758 | 963,798 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,269,765 | 995,511 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,644,879 | 954,830 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,958,930 | 963,821 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,865,256 | 911,617 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,085,512 | 269,358 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,208,023 | 242,575 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,168,241 | 248,562 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $939,564 | 248,562 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $684,848 | 214,350 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $53,701 | 27,539 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $66,467 | 42,882 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $66,467 | 42,882 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $65,180 | 42,882 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $56,175 | 42,882 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $53,173 | 42,882 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $59,177 | 42,882 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $72,899 | 42,882 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $208,114 | 100,055 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $125,068 | 108,755 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $118,542 | 108,755 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $270,799 | 108,755 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $168,406 | 79,437 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||